Amarin Corp Plc (AMRN)

[mclim]

According 4th Q CC

"Inventory levels at wholesalers ended 2018 at levels which were consistent with industry norms. We do not believe that our 2018 revenues were significantly impacted by shifts in wholesaler inventory levels. Our net product revenue in Q4 was slightly higher than what may have been calculated by review of prescription data from independent sources such as Symphony Health and IQVIA.
As described previously, these sources use various sampling techniques to estimate prescription levels. They are only estimates as demonstrated by the different results reported by different sources. The techniques they use appear to be more effective over long periods of time compared to short periods. It is our speculation that actual prescription levels for Vascepa in the fourth quarter may have increased faster than what was reported by these sources."

Perhaps 4th Q scripts were much higher than reported, and 1st Q might even be higher, so perhaps we can get to 90m plus.